Pembrolizumab with and without sacituzumab govitecan as first-line treatment for metastatic non-small-cell lung cancer (NSCLC) with PD-L1 TPS >=50%: phase 3 KEYNOTE-D46/EVOKE-03 study
Pembrolizumab;Sacituzumab Govitecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Pembrolizumab with and without sacituzumab govitecan as first-line treatment for metastatic non-small-cell lung cancer (NSCLC) with PD-L1 TPS >=50%: phase 3 KEYNOTE-D46/EVOKE-03 study ### Output: Pembrolizumab;Sacituzumab Govitecan